166.95

0.81% 1.34

Genedx Holdings Corp (WGS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Genedx Holdings Corp stock is traded at $166.95, with a volume of 203.25K. It is up +0.81% in the last 24 hours and up +21.44% over the past month. GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. The company is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Previous Close:

$165.61

Open:

$165.21

24h Volume:

203.25K

Relative Volume:

0.39

Market Cap:

$4.83B

Revenue:

$267.23M

Net Income/Loss:

$-83.50M

P/E Ratio:

-53.68

EPS:

-3.11

Net Cash Flow:

$-59.99M

1W Performance:

+13.92%

1M Performance:

+21.44%

6M Performance:

+138.43%

1Y Performance:

+110.19%

1-Day Range:

$163.00

$168.13

1-Week Range:

$146.55

$170.75

52-Week Range:

$55.17

$170.75

Genedx Holdings Corp Stock (WGS) Company Profile

Name

Genedx Holdings Corp

Sector

Healthcare (1139)

Industry

Diagnostics & Research (54)

Phone

888-729-1206

Address

333 LUDLOW STREET, STAMFORD

Employee

1,000

Twitter

Next Earnings Date

2025-02-18

Latest SEC Filings

WGS's Discussions on Twitter

Compare WGS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WGS Genedx Holdings Corp	166.95	4.79B	267.23M	-83.50M	-59.99M	-3.11
TMO Thermo Fisher Scientific Inc	590.83	222.89B	43.74B	6.58B	6.11B	17.31
DHR Danaher Corp	226.78	161.37B	24.27B	3.50B	5.02B	4.8589
IDXX Idexx Laboratories Inc	752.88	60.36B	4.17B	1.03B	940.22M	12.61
A Agilent Technologies Inc	153.50	43.70B	6.95B	1.30B	1.09B	4.5714
IQV Iqvia Holdings Inc	230.01	39.48B	15.90B	1.28B	2.21B	7.2842

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-20-25	Initiated	Canaccord Genuity	Buy
Jul-09-25	Initiated	Piper Sandler	Overweight
May-15-25	Initiated	Guggenheim	Buy
May-09-25	Upgrade	Jefferies	Hold → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jul-10-24	Initiated	Craig Hallum	Buy
Jun-03-24	Resumed	Jefferies	Hold

View All

Genedx Holdings Corp Stock (WGS) Latest News

Nov 28, 2025

Is GeneDx Holdings Corp Equity Warrant a good long term investmentRisk Adjusted Returns & Small Budget Wealth Building - earlytimes.in

Nov 28, 2025

Nov 27, 2025

Is GeneDx Holdings Corp. Equity Warrant stock positioned well for digital economyTrade Performance Summary & Low Risk High Win Rate Picks - moha.gov.vn

Nov 27, 2025

Nov 26, 2025

Can GeneDx Holdings Corp. stock beat market expectations this quarter2025 Earnings Surprises & Risk Adjusted Swing Trade Ideas - moha.gov.vn

Nov 26, 2025

GeneDx Holdings Corp Stock Analysis and ForecastCandlestick Pattern Analysis & High Profit Investment Ideas - earlytimes.in

Nov 26, 2025

Nov 24, 2025

GeneDx Holdings Corp stock hits 52-week high at 148.0 USD - Investing.com Nigeria

Nov 24, 2025

GeneDx Holdings Corp stock hits 52-week high at 148.0 USD By Investing.com - Investing.com South Africa

Nov 24, 2025

Nov 21, 2025

Why GeneDx Holdings Corp. Equity Warrant stock could rally in 2025Weekly Risk Report & AI Forecast Swing Trade Picks - newser.com

Nov 21, 2025

Guggenheim Reaffirmed Buy on GeneDx at October End, Lifted Price Target to $170 After Q3 Beat - MSN

Nov 21, 2025

Nov 20, 2025

How rising interest rates impact GeneDx Holdings Corp. stockJuly 2025 Movers & Reliable Volume Spike Alerts - newser.com

Nov 20, 2025

Nov 19, 2025

GeneDx at Jefferies London: Strategic Expansion in Pediatrics By Investing.com - Investing.com South Africa

Nov 19, 2025

Price action breakdown for GeneDx Holdings Corp.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com

Nov 19, 2025

Is GeneDx Holdings Corp. stock a top pick in earnings seasonStock Surge & Low Risk High Reward Trade Ideas - newser.com

Nov 19, 2025

Key metrics from GeneDx Holdings Corp. Equity Warrant’s quarterly dataQuarterly Trade Report & Low Volatility Stock Recommendations - newser.com

Nov 19, 2025

GeneDx at Jefferies London: Strategic Expansion in Pediatrics - Investing.com

Nov 19, 2025

Visual trend scoring systems applied to GeneDx Holdings Corp. Equity WarrantEarnings Recap Report & Accurate Technical Buy Alerts - newser.com

Nov 19, 2025

Exit strategy if you’re trapped in GeneDx Holdings Corp.M&A Rumor & Safe Swing Trade Setups - newser.com

Nov 19, 2025

GeneDx (WGS): Valuation Insights After Strong Q3, Raised Guidance, and New Genomics Advances - Sahm

Nov 19, 2025

Price action breakdown for GeneDx Holdings Corp. Equity WarrantMarket Trend Review & Expert-Curated Trade Recommendations - newser.com

Nov 19, 2025

How institutional ownership impacts GeneDx Holdings Corp. Equity Warrant stockPortfolio Profit Report & Short-Term Trading Opportunity Alerts - newser.com

Nov 19, 2025

Nov 18, 2025

GeneDx Holdings Corp. stock prediction for this week2025 Market Outlook & Weekly High Momentum Picks - newser.com

Nov 18, 2025

Nov 17, 2025

How GeneDx Holdings Corp. Equity Warrant stock performs in rising dollar environment - newser.com

Nov 17, 2025

Will GeneDx Holdings Corp. Equity Warrant stock continue dividend increasesJuly 2025 Spike Watch & Low Risk High Win Rate Stock Picks - newser.com

Nov 17, 2025

Could Expanding Rare Disease Data Give GeneDx (WGS) a Sustainable Edge in Precision Medicine? - Sahm

Nov 17, 2025

Nov 16, 2025